ArticleInternational journal of general medicine2025
Erratum: KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma [Corrigendum].
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.